GlassScriptPhysician profile
Bria D Hull
NPI 1205209475
$1,305.15
in general payments reported to CMS, 2019-2025
15 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.62 · 2022: $394 · 2023: $287 · 2024: $273 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838 · Education: $18.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.63 |
| Education | $18.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $392.69 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $245.12 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $228.71 | 2022-2023 | |
| Lilly USA, LLC | $139.55 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $54.30 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $40.26 | 2024-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.71 | 2022-2024 | Synjardy, Jardiance |
| Janssen Pharmaceuticals, INC | $35.42 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $27.96 | 2021-2022 | |
| Glaxosmithkline, LLC. | $19.95 | 2025 | Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $19.54 | 2023 | Gemtesa |
| Boston Scientific Corporation | $19.50 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $18.99 | 2023 | Evkeeza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.20 | 2022 | |
| Arbor Pharmaceuticals, INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bria Hull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.